″We anticipate this novel, clinically-backed technology can support our category leadership strategy while expanding access to care for individuals who need personalized treatment,″ said Jim Cassidy, president, Neuromodulation, Boston Scientific. ″Upon close, we look forward to working with the Relievant team to explore opportunities to bring this high-growth therapy to a wider population of people living with chronic low back pain.″

Randy Theken, Founder of Theken Companies, said of the acquisition, “I was truly overwhelmed by the technology created by the VisionAir team at Cleveland Clinic. The VisionAir 3D Patient-Specific Stents provide significantly improved stent life and an improved patient quality of life. This is exciting not only for the pulmonary field, but for the potential to apply this technology to other medical devices.”

Abdul Mutlib, CEO of Frontage Laboratories.  “Nucro-Technics has been recognized as a leader in the Canadian CRO market for over 50 years, and its unparalleled client services are a perfect match for the culture of Frontage Laboratories.  This acquisition not only significantly strengthens our presence in Canada, but also will enable the combined organization to offer a more expansive suite of services to clients across the globe.  We are looking forward to partnering with the Nucro team to deliver the world-class expertise that clients have come to expect from us.”

Thomas Scientific’s CEO, Stan Haas, stated, “We at Thomas Scientific are very proud to partner with an industry veteran in Billy Day and his entire team. Billy has built a business over the past 45 years founded on providing personalized service and many great product brands to meet the stringent needs of their customers. By Day Associates joining the Thomas Scientific family of companies, the customers will have access to an even broader portfolio of products and a national network of distribution centers and inventory to meet their needs now and into the future.”

“MD Revolution offers not only extensive experience but also the best technology platform, and proven SaaS offering, to serve our growing client base” said Rick Griffin, CEO, NavCare. “We share the same culture and desire to provide exceptional personalized care to our patients, along with maintaining the highest clinical standards.”